These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 37257121
41. Immunogenicity and safety of a pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type B conjugate combination vaccine (Pentaxim) with hepatitis B vaccine. Dutta AK, Verghese VP, Pemde HK, Mathew LG, Ortiz E. Indian Pediatr; 2009 Nov; 46(11):975-82. PubMed ID: 19955579 [Abstract] [Full Text] [Related]
44. Persistence of hepatitis B immune memory until 9-10 years of age following hepatitis B vaccination at birth and DTaP-IPV-HB-PRP∼T vaccination at 2, 4 and 6 months. Kosalaraksa P, Chokephaibulkit K, Benjaponpitak S, Pancharoen C, Chuenkitmongkol S, B'Chir S, Da Costa X, Vidor E. Hum Vaccin Immunother; 2018 May 04; 14(5):1257-1265. PubMed ID: 29333947 [Abstract] [Full Text] [Related]
45. Long-term immunogenicity assessment of a DTaP-IPV//PRP-T vaccine given at 2, 4, 6 and 18-19 months of age, and immunogenicity and safety of a DTaP-IPV vaccine given as a booster dose at 4 to 6 years of age in Thai children. Pancharoen C, Chotpitayasunondh T, Chuenkitmongkol S, Ortiz E. Southeast Asian J Trop Med Public Health; 2012 May 04; 43(3):687-98. PubMed ID: 23077849 [Abstract] [Full Text] [Related]
47. Immunogenicity and safety profile of a primary dose of bivalent oral polio vaccine given simultaneously with DTwP-Hb-Hib and inactivated poliovirus vaccine at the 4th visit in Indonesian infants. Fadlyana E, Dhamayanti M, Tarigan R, Mulia Sari R, Sjafri Bachtiar N, Kartasasmita CB, Rusmil K. Vaccine; 2020 Feb 18; 38(8):1962-1967. PubMed ID: 31982261 [Abstract] [Full Text] [Related]
48. A fully liquid diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis--Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants. Lin TY, Wang YH, Chang LY, Huang YC, Kao HT, Lin PY, Lu HK, Chavand P, Ortiz E. Int J Infect Dis; 2007 Mar 18; 11(2):129-36. PubMed ID: 16762579 [Abstract] [Full Text] [Related]
52. Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of age. Carlsson RM, Claesson BA, Selstam U, Fagerlund E, Granström M, Blondeau C, Hoffenbach A. Pediatr Infect Dis J; 1998 Nov 18; 17(11):1026-33. PubMed ID: 9849987 [Abstract] [Full Text] [Related]
53. A randomized, open label trial to evaluate and compare the immunogenicity and safety of a novel liquid hexavalent DTwP-Hib/Hep B-IPV (EasySix™) to licensed combination vaccines in healthy infants. Mohanty L, Sharma S, Behera B, Panwar S, Paliwal C, Gupta A, Chilkoti DC, Singh A. Vaccine; 2018 Apr 19; 36(17):2378-2384. PubMed ID: 29580640 [Abstract] [Full Text] [Related]
56. Immunogenicity and safety of a DTaP-IPV//PRP-T vaccine (Pentaxim) booster during the second year of life in Thai children primed with an acellular pertussis combined vaccine. Thisyakorn U, Pancharoen C, Chuenkitmongkol S, Ortiz E. Southeast Asian J Trop Med Public Health; 2009 Mar 19; 40(2):282-94. PubMed ID: 19323013 [Abstract] [Full Text] [Related]